Advertisement
Advertisement

TCRT

TCRT logo

Alaunos Therapeutics, Inc. Common Stock

1.98
USD
Sponsored
-0.01
-0.50%
Aug 10, 15:51 UTC -4
Closed
exchange

After-Market

1.91

-0.07
-3.54%

Alaunos Therapeutics, Inc. Common Stock Profile

About

Alaunos Therapeutics Inc. is a clinical-stage oncology-focused cell therapy company. It focused on developing T-cell receptor therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform. Alaunos Therapeutics Inc., formerly known as Ziopharm Oncology Inc., is based in HOUSTON.

Info & Links

CEO

Holger Weis

Headquarters

501 E LAS OLAS BLVD, SUITE 300
FORT LAUDERDALE, FL 33301, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.alaunos.com

Auditor

Cherry Bekaert LLP

Share holders

131

Employees

1

Alaunos Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.66M

Enterprise Value

4.31M

Enterprise Value/EBITDA(ttm)

-1.04

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.67

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-7441.67%

Return on Equity(ttm)

-165.94%

Return on Invested Capital(ttm)

-189.64%

Return on Assets(ttm)

-123.50%

Income Statement

Revenue(ttm)

3.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

3.00K

EBITDA(ttm)3

-4.14M

Net Income Available to Common(ttm)

-4.11M

Diluted EPS(ttm)

-2.13

Share Statistics

Beta (5Y Monthly)

-1.00

52-Week Change

-19.84%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

24.42M

Dividend Yield

0.00%

Float4

20.48M

% Held by Insiders

16.14%

% Held by Institutions

27.72%

Balance Sheet

Total Cash(mrq)

354.00K

Total Cash Per Share(mrq)

0.01

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.63%

Quick Ratio(mrq)

1.63%

Book Value Per Share(mrq)

0.54

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.53

Free Cash Flow(ytd)

-1.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement